Moderna Inc. said on Thursday it has agreed to push back some COVID-19 vaccine deliveries to the European Union by several months to later in 2022 or early next year.
Shares of Moderna fell nearly 2 percent before the bell over the delay, even though the company stuck to its vaccine sales forecast of $21 billion for 2022.
